INTRODUCTION {#S1}
============

The mitochondrial respiratory chain (MRC) consists of four enzymatic multimeric complexes (CI to CIV) and two mobile electron carriers (coenzyme Q and cytochrome *c*), which catalyze electron transfer from reducing equivalents (NADH and FADH~2~) to molecular oxygen. The process is coupled to the generation of a proton gradient that drives ATP synthesis by the ATP synthase through oxidative phosphorylation (OXPHOS). The proton-pumping complexes (CI, CIII, and CIV) can assemble into higher supramolecular structures known as supercomplexes (SCs) ([@R12]; [@R36]). Mammalian CI is primarily found assembled in SCs, either interacting with the CIII dimer (CIII~2~) to form SC I+III~2~, or with both CIII~2~ and CIV to form SC I+III~2~+IV~1~, to which additional CIV monomers can be added. These structures are known as the respirasomes ([@R36]), since they were initially proposed to contain all the components required to transfer electrons from NADH to molecular oxygen ([@R3]). In addition, CIII~2~ and CIV form the scarce SC III~2~+IV that coexists with the relatively abundant SCs I+III~2~+IV~0--4~, as well as with CIII~2~, CIV~2~, and monomeric CIV ([@R26]). The structural and functional organization of the MRC complexes is currently considered to be dynamic, where the proportion of free complexes and SCs is possibly modulated to adapt ATP production to changing cellular metabolic demands and environmental conditions ([@R1]). However, the functional roles of the SCs remain intriguing. The general arrangement of the MRC in SCs was initially suggested to confer catalytic advantages to the system, as it was proposed to enhance the electron flux through substrate channeling ([@R6]), and to allow optimization of the available metabolic substrates via partitioned coenzyme Q and cyto- chrome *c* pools ([@R22]). However, direct spectroscopic studies argued in favor of single coenzyme Q and cytochrome *c* pools ([@R7]; [@R44]), and a definitive demonstration that quinone and quinol diffuse freely in and out of SCs has recently come from studies that incorporated an alternative quinol oxidase into mammalian heart mitochondrial membranes and showed to establish a competing pathway for quinol oxidation ([@R15]). Therefore, the catalytic relevance of the SCs remains questioned ([@R26]; [@R29]). In addition, the I+III~2~+IV~n~ respirasomes have been proposed to stabilize CI ([@R31]; [@R37]) and to prevent the production of CI-derived reactive oxygen species (ROS) ([@R27]). The recently defined high-resolution cryoelectron microscopy (cryo-EM) reconstructions of the mammalian respirasome ([@R18]; [@R24]; [@R41]; [@R47]) are expected to be instrumental to unveil the potential functional properties of the SCs. Structural studies of the SC I+III~2~+IV~1~ from bovine, ovine, and porcine heart mitochondria showed that CIV is positioned at the distal end of the membrane arm of CI and adjacent to CIII~2~. In addition, structural analyses in HEK293 cells showed the first architecture of the human respirasome, as well as the arrangement of the MRC complexes in a novel circular structure termed the megacomplex I~2~+III~2~+IV~2~ ([@R19]), where CIII~2~ forms a central core surrounded by two copies each of CI and CIV. The availability of these structures has only reinforced the intrigue about the biogenetic mechanisms and players that trigger the formation of the SCs. Besides the presence of the phospholipid cardiolipin ([@R30]), SCs formation requires the action of specific assembly factors both in yeast ([@R9]; [@R40]; [@R42]; [@R45]) and mammals ([@R9]; [@R13]; [@R20]; [@R22]; [@R32]; [@R33]), although their specific functions remain under debate.

A controversial case involves the role of the protein COX7A2- like (COX7A2L, SCAFI, or COX7RP), highly homologous to the CIV subunit COX7A. COX7A2L was initially proposed to be central for the inclusion of CIV in SCs III~2~+IV and I+III~2~+IV~1--4~ ([@R22]). Two COX7A2L variants were detected in commonly used laboratory mouse strains: a full-length 113-amino acids (long) protein present in CD1 mice, and a 111- amino acids (short) protein present in the C57BL/6 and BALB/c strains that missed two conserved residues (V72-P73) important for its stability and function in SCs formation ([@R22]). However, several groups reported the presence of respirasomes in C57BL/6 mice ([@R4]; [@R20]; [@R22]; [@R32]; [@R46]), and cultured human cells silenced for *COX7A2L* expression also showed a specific requirement of COX7A2L for SC III~2~+IV assembly but not for respirasomes accumulation ([@R33]). These studies highlighted the preferential interaction of COX7A2L with CIII~2~ and to a minor extent with monomeric CIV ([@R33]), which suggested an additional CIII-related mechanism of action for COX7A2L. There is currently a consensus that the full-length COX7A2L is required to promote SC III~2~+IV formation and that it does so by binding independently to both CIII~2~ and CIV ([@R11]; [@R33]; [@R48]). It is also agreed that COX7A2L depletion does not affect the accumulation of the respirasomes I+III~2~+IV~1--4~ in some mouse tissues such as heart, as well as in *COX7A2L*- silenced human cells ([@R32]; [@R33]; [@R46]). Interestingly, the short COX7A2L iso- form in C57BL/6 mice induced tissue-specific differences in the levels of the larger respirasomes I+III~2~+IV~2--4~, which were less abundant in liver than in heart mitochondria ([@R46]). Even the respirasome I+III~2~+IV~1~ was shown to be unstable in some tissues according to some reports ([@R11]), but not to others ([@R13]; [@R32]; [@R43]; [@R46]). Based on proteomics analyses of the SCs subunit composition, it was hypothesized that the expression of tissue-specific isoforms of CIV subunits (e.g heart-muscle/liver COX7A1/COX7A2) could substitute COX7A2L in the respirasomes, inducing slight structural alterations in the CIV holocomplex that would differentially affect the assembly of the SCs in the presence of a specific COX7A variant ([@R11]), a possibility that remains to be experimentally demonstrated.

To unambiguously determine the function of COX7A2L in the organization of the human respiratory chain, we have used transcription activator-like effector nucleases (TALENs) technology to generate stable human *COX7A2L*-knockout (*COX7A2L*-KO) lines in HEK293T and in glioblastoma U87 cells, which were complemented either with the wild-type (WT) human COX7A2L, or with a mutant variant carrying an in-frame 6-bp deletion similar to that previously identified in the C57BL/6 mouse strain. Our results confirm that WT (long) COX7A2L is specifically required for the assembly of SC III~2~+IV and the accumulation of megacomplexes, but dispensable for respirasome (or SCs I+III~2~+IV~1~) biogenesis, and reconcile an array of previous observations. *De novo* assembly studies show that COX7A2L regulates the assembly kinetics of the respirasomes probably through the modulation of CIII~2~ levels. Biochemical data also demonstrate that the mutant COX7A2L variant does not support SC III~2~+IV assembly because, despite being able to bind to both CIII~2~ and SC I+III~2~, it cannot interact with CIV or CIV-containing SCs. Functional substrate competition assays showed no differences in mitochondrial respiration between control and *COX7A2L*-KO cells, even under conditions of nutritional, environmental, or oxidative cellular stress. We conclude that by preventing the formation of SC III~2~+IV, COX7A2L establishes a checkpoint for the regulation of CIII~2~ levels and its incorporation into specific SCs. Most importantly, COX7A2L promotes MRC remodeling without affecting mitochondrial bioenergetics.

RESULTS {#S2}
=======

TALEN-Mediated Generation of *COX7A2L*-KO Cell Lines {#S3}
----------------------------------------------------

To determine the requirement of human COX7A2L for mitochondrial SCs formation, and specifically for the assembly of the respirasomes, we used the TALEN gene-editing approach ([@R10]; [@R25]) to create stable human *COX7A2L*-KO lines in HEK293T (human embryonic kidney) cells. A TALEN pair was designed to target a region within the first exon of the *COX7A2L* gene immediately downstream the start codon ([Figure 1A](#F1){ref-type="fig"}). We co-transfected HEK293T cells with the TALEN pair, and subsequently, single clones were isolated by size cell sorting and analyzed for mutations leading to COX7A2L protein loss. More than 100 clones were screened by immunoblotting from cell extracts using a specific anti- COX7A2L antibody. We selected five promising candidates that completely lack the COX7A2L protein ([Figure 1B](#F1){ref-type="fig"}). The *COX7A2L* gene was sequenced in two of these clones and found to carry KO mutations. Clone KO1 (C2E11) is homozygous and clone KO2 (C1C3) is compound heterozygous, both carrying *COX7A2L* alleles with short deletions involving the start codon and leading to the complete absence of COX7A2L ([Figure 1C](#F1){ref-type="fig"}).

*COX7A2L*-KO Cells Display Absence of SC III~2~+IV with Normal Respirasome Levels and Increased CIII~2~ Levels and Activity {#S4}
---------------------------------------------------------------------------------------------------------------------------

To analyze the pattern of supramolecular assemblies of MRC complexes resulting from the total absence of COX7A2L in human cells, we performed a first exploration in digitonin-solubilized cell extracts from WT and *COX7A2L*-KO cells by blue native (BN)-PAGE followed by CI-in gel activity (IGA) and immunoblotting. Our results unambiguously show that human COX7A2L is essential for the formation of SC III~2~+IV, but its loss does not affect the basic respirasome (or SCs I+III~2~+IV~1~) that accumulates equally in WT and KO cells ([Figure 1D](#F1){ref-type="fig"}). Similar results were obtained when using mitochondria-enriched fractions from WT HEK293T, KO1, and KO2 clones ([Figure 2A](#F2){ref-type="fig"}). However, some scarce SCs larger than the basic respirasome I+III~2~+IV~1~, occasionally appeared to be at lower levels in some experiments with HEK293T cells. These SCs could contain multiple CIV units (I+III~2~+IV~2--4~) but are also compatible with the recently described respiratory megacomplex I~2~+III~2~+IV~2~ ([@R19]). For simplification, in the figures we have labeled them as MegaC (megacomplexes). The loss of these larger SCs was clearly re-produced in a different model of human *COX7A2L*-KO in U87 glioblastoma cells (see below), suggesting that these MRC structures fail to assemble in the absence of functional COX7A2L, but might also be more labile than in WT mitochondria.

To assess whether the stability of the respirasomes depends on COX7A2L, we exposed mitochondria-enriched fractions from WT and *COX7A2L*-KO cells to varying concentrations of digitonin and analyzed the extracts by BN-PAGE followed by CI- and CIV-IGAs or immunoblotting ([Figure S1](#SD1){ref-type="supplementary-material"}). Stringent SCs extraction conditions using increasing (4--40 mg/mg) digitonin-to-protein ratios ([Figure S1A](#SD1){ref-type="supplementary-material"}) led to a parallel disintegration of the respirasomes (SCs I+III~2~+IV~n~) and consequent accumulation of SC I+III~2~ and free CI in both cell types. Only when we used an extremely harsh 40 mg/mg digitonin:protein ratio were the respirasomes slightly more unstable in *COX7A2L*-KO than in WT cells. Milder SCs extraction conditions using decreasing (4--1 mg/mg) digitonin-to-protein ratios, revealed no differences in the levels of SC I+III~2~+IV~1~ between *COX7A2L*-KO and WT cells ([Figure S1B](#SD1){ref-type="supplementary-material"}), but a clear decrease in the abundance of larger SCs (indicated with an asterisk) in *COX7A2L*-KO cells ([Figures 2A and 2B](#F2){ref-type="fig"}), further suggesting that COX7A2L may be required for the normal assembly or stability of these megastructures. On the contrary, the abundance and stability of monomeric and dimeric CIV were not affected by the absence of COX7A2L ([Figures 2A and 2B](#F2){ref-type="fig"}).

We next used a two-dimensional (2D)-BN/SDS-PAGE system to analyze in detail the pattern of SCs in *COX7A2L*-KO cells and the co-localization of COX7A2L with all MRC structures in WT cells. Although we had previously reported that COX7A2L associates with pre-CIII~2~ before the incorporation of the RISP subunit([@R33]), RISP assembly is not affected in *COX7A2L*-KO cells as it was detected in CIII~2~, and in SCs I+III~2~ and I+III~2~+IV~1-n~ ([Figure 2A](#F2){ref-type="fig"}). However, the accumulation of CIII~2~ was significantly increased by \~2-fold in the absence of COX7A2L ([Figures 1D](#F1){ref-type="fig"}, [2A--2D](#F2){ref-type="fig"}, [S1A](#SD1){ref-type="supplementary-material"}, and [S1B](#SD1){ref-type="supplementary-material"}). The increase in CIII~2~ levels was not only a consequence of redistribution from the unassembled SC III~2~+IV. A boost in CIII~2~ levels was detected when using *COX7A2L*-KO mitochondrial extracts prepared not only in the presence of digitonin but also in the presence of lauryl maltoside ([Figure 2D](#F2){ref-type="fig"}), which disrupts SC integrity, indicating that the total amount of assembled CIII~2~ is increased. In agreement, spectrophotometric measurements of MRC enzyme activities showed that CIII activity was specifically enhanced by \~40% in the KOs ([Figure 2E](#F2){ref-type="fig"}), consistent with the accumulation of CIII~2~ in these cells.

All of the phenotypes described in *COX7A2L*-KO cells in this section, particularly the absence of SC III~2~+IV and the accumulation of CIII~2~, were specific since they were restored by the over- expression of recombinant COX7A2L-Myc-DDK in both KOs ([Figures S2A--S2C](#SD1){ref-type="supplementary-material"}), thus eliminating the possibility of off-target effects that could have arisen during the *COX7A2L* gene disruption. Tagged-COX7A2L incorporated into the same MRC structures as the endogenous COX7A2L ([Figure S2B](#SD1){ref-type="supplementary-material"}), and its mild overexpression (2- to 3-fold) did not induce any aberrant pheno- type ([Figure S2](#SD1){ref-type="supplementary-material"}).

*COX7A2L*-KO Cells Display a Boost in CIII~2~ Biogenesis in Parallel with Slower Respirasome Assembly Kinetics {#S5}
--------------------------------------------------------------------------------------------------------------

We next analyzed the assembly kinetics of MRC complexes and SCs by doxycycline-induced reversible inhibition of mitochondrial translation in WT and *COX7A2L*-KO cells. Doxycycline was removed from the cell culture media after 6 days of treatment, and samples were collected at different time points (0, 6, 15, 24, 48, 72, and 96 hr). To follow the reappearance of newly assembled CIII~2~, CIV, CIV~2~, and SCs, digitonin-solubilized mitochondria were separated by BN-PAGE and subsequently analyzed by either CI-IGA assays ([Figures 3A and 3B](#F3){ref-type="fig"}) or immunoblot using antibodies that recognize CORE2 (CIII), COX1 (CIV; not shown), and COX5A (CIV) ([Figures 3C and 3D](#F3){ref-type="fig"}). Following 6 days of doxycycline treatment (time 0 hr), only residual levels of CI, CIV, and CIII~2~ (5%--10% of untreated cells) were detected in either control or KO cells ([Figures 3A--3D](#F3){ref-type="fig"}). The treatment did not affect CII levels, as expected, since CII lacks mtDNA-encoded subunits. Once mitochondrial translation resumed (times 6--96 hr), the SC III~2~+IV formed *de novo* only in the WT cells ([Figures 3C and 3D](#F3){ref-type="fig"}). The levels of CIV and CIV~2~ increased at similar rates in WT and *COX7A2L*-KO cells ([Figures 3C and 3D](#F3){ref-type="fig"}), ruling out a role for COX7A2L in the biogenesis of this complex. On the contrary, the rate of CIII~2~ biogenesis, as shown for its steady-state levels in [Figure 2](#F2){ref-type="fig"}, was markedly faster in the KOs than in the WT cells ([Figures 3C and 3D](#F3){ref-type="fig"}). These data indicate a deregulation of CIII~2~ levels in the absence of COX7A2L, suggesting that this protein establishes a regulatory checkpoint in CIII~2~ biogenesis. Immunoblot analysis of CIII subunit levels during the recovery from the doxycycline treatment ([Figure 3E](#F3){ref-type="fig"}) and in the steady state ([Figure 3F](#F3){ref-type="fig"}) showed no significant differences in the steady-state levels of CIII subunits between WT and KOs, which indicate that a larger pool of unassembled sub- units may exist in the WT cells. Therefore, we propose that the CIII~2~ increase in the KOs is a consequence of a more efficient CIII~2~ assembly/stability rather than increased *de novo* synthesis of CIII subunits. Strikingly, the reappearance of the respirasomes I+III~2~+IV~n~ was clearly delayed in the *COX7A2L*-KO cells ([Figures 3A--3D](#F3){ref-type="fig"}), but it reached levels comparable to the WT at later time points (78--96 hr; [Figures 3A--3D](#F3){ref-type="fig"}) and in the steady state ([Figure 2](#F2){ref-type="fig"}). These results suggest that, although the lack of COX7A2L does not prevent the formation of the respirasomes, it hampers their assembly efficiency perhaps by increasing the threshold of CIII~2~ levels required to start the process ([@R31]).

To validate the hypotheses raised from the doxycycline experiments, we took into account the current model for CIII~2~ assembly ([Figure 3G](#F3){ref-type="fig"}), which includes the binding of COX7A2L to pre-CIII~2~ prior to the incorporation of subunits UQCRFS1 and UQCR11 ([@R16]; [@R33]). The process of CIII~2~ biogenesis, however, is not known in detail. For example, it remains unclear at which stage CIII~2~ dimerization occurs. Here, we performed import/assembly assays in isolated WT and *COX7A2L*-KO mitochondria with specific ^35^S-methionine-radiolabeled CIII precursors synthesized *in vitro*, in the presence and absence of mitochondrial membrane potential ([Figure 3H](#F3){ref-type="fig"}). We chose to synthesize and import RISP (UQCRFS1; [Figure 3I](#F3){ref-type="fig"}) and UQCR11 ([Figure 3J](#F3){ref-type="fig"}), two late assembly proteins that are known to incorporate after the binding of COX7A2L to pre-CIII~2~. In WT mitochondria, UQCRFS1 and UQCR11 incorporated into several subcomplexes up to the CIII~2~ and followed by later incorporation into SCs (I+III~2~ and I+III~2~+IV~n~). In *COX7A2L*-KO mitochondria, UQCRFS1 and UQCR11 incorporated more efficiently into the same intermediates as well as into CIII~2~ than in WT mitochondria. On the contrary, the incorporation signals of these two radiolabeled proteins into SCs were less marked in the KO than in WT cells. Together, our import data show enhanced incorporation of newly imported proteins into CIII~2~ assembly intermediates and attenuated formation of CIII~2~-containing SCs in the *COX7A2L*-KO, suggesting that endogenous CIII~2~ biogenesis is preferentially boosted and assembly intermediates are more abundant in *COX7A2L*-KO than in WT mitochondria.

Mitochondrial Bioenergetics in *COX7A2L*-KO Cells Is Indistinguishable from WT in Normal Physiological Conditions or under CI Deficiency {#S6}
----------------------------------------------------------------------------------------------------------------------------------------

To ascertain the functional consequences of COX7A2L and SC III~2~+IV depletion, we performed high-resolution endogenous oxygraphy to measure coupled cell respiration in intact cells, which is unaffected in the *COX7A2L*-KO clones (not shown).

Furthermore, substrate-driven competition was determined by treating digitonin-permeabilized cells supplemented with NADH- linked substrates (pyruvate, glutamate, malate) and FADH~2~-linked substrates (succinate, glycerol-3-phosphate), with specific inhibitors of CI (piericidin A or rotenone) or CII (malonate). This experimental procedure allowed us to determine the respective contribution of CI and CII in feeding the respiratory chain (RC) with electrons during uncoupled respiration ([Figures 4A--4D](#F4){ref-type="fig"}). In contrast with previous results in liver mitochondria from C57BL/6 mice ([@R22]) and in line with results obtained by some of us in liver and heart mitochondria from C57BL/6J and C57BL/6N mice ([@R32]), substrate-driven competition was not affected in the *COX7A2L*-KO clones. Also, no effect on respiration resulted from COX7A2L overexpression ([Figures 4A--4D](#F4){ref-type="fig"}). These results indicate that, in standard cell culture conditions, neither COX7A2L nor SC III~2~+IV have a sub- stantial functional effect on electron flow through the MRC.

In human cells, more than 90% of CI is present in the respirasomes and the SC III~2~+IV only constitutes \~5% of the total amount of MRC structures ([@R31]). Taking this MRC organization into account, we contemplated that, by limiting the enzymatic activity of CI, we could discern whether the absence of SC III~2~+IV and the accumulation of CIII~2~ in the *COX7A2L*-KO clones affect substrate competitive oxidation. To induce a partial inhibition of CI activity, we first treated the cells with 10 nM rotenone, 1.2 mM piericidin A, or the control vehicle (0.05% or 8.5 mM ethanol) for 24 hr ([Figure 4E](#F4){ref-type="fig"}). CI inhibition did not significantly alter the distribution of MRC complexes and SCs in WT or KO cells ([Figure 4F](#F4){ref-type="fig"}). Piericidin A treatment resulted in a comparable \~50% decrease in pyruvate-glutamate-malate + succinate-glycerol-3-phosphate (G3P) oxidation and similar substrate contribution in WT and KO digitonin-per-meabilized cells ([Figure 4G](#F4){ref-type="fig"}).

Mitochondrial Bioenergetics in *COX7A2L*-KO Cells Is Indistinguishable from WT under Nutritional or Environmental Stress {#S7}
------------------------------------------------------------------------------------------------------------------------

The faster CIII~2~ biogenesis and slower respirasome assembly rate observed in *COX7A2L*-KO cells would be consistent with a role for COX7A2L in accelerating SCs assembly to attend physiological needs or to recover from insults that could damage MRC complexes. In fact, it has been proposed that COX7A2L is induced, incorporated into CIV, and then enhances CIV activity under cellular stress conditions such as endoplasmic reticulum (ER) stress or ischemia ([@R48]). Therefore, we assessed whether stressed HEK293T *COX7A2L*-KO cells could reveal a bioenergetics role for COX7A2L. Preliminary tests informed us that HEK293T cells do not exhibit a robust response to general stresses such as heat shock ([Figure S3A](#SD1){ref-type="supplementary-material"}), and although they respond to oxidative stress ([Figures S3D and S3E](#SD1){ref-type="supplementary-material"}), COX7A2L is not induced in the conditions tested ([Figure S3B](#SD1){ref-type="supplementary-material"}). Among the several cell lines examined, glioblastoma U-87 exhibited the most robust stress response ([Figures S3A and S3B](#SD1){ref-type="supplementary-material"}) and was used to generate a new *COX7A2L*-KO (U- KO). Two U-KO clones were obtained ([Figures S4A and S4B](#SD1){ref-type="supplementary-material"}). Since they exhibited a similar phenotype that was fully complemented by *COX7A2L* reconstitution ([Figures 5B](#F5){ref-type="fig"}, [S3C](#SD1){ref-type="supplementary-material"}, and [S3D](#SD1){ref-type="supplementary-material"}), U-KO1 was used for subsequent experiments.

The pattern of MRC complexes and SCs was similar in HEK293T and U87 WT cells. However, SCs and MegaCs seemed more abundant in U87 ([Figures 5A and 5B](#F5){ref-type="fig"}). The absence of *COX7A2L* in U87 cells prevented the assembly of SC III~2~+IV and enhanced CIII~2~ levels ([Figures 5A and 5B](#F5){ref-type="fig"}) and delayed the assembly of the respirasomes ([Figure S4C](#SD1){ref-type="supplementary-material"}) as seen in HEK293T cells. It further limited the accumulation of SCs larger than the basic respirasome SC I+III~2~+IV~1~, although the detection of some traces of these SCs in U-KO cells could reflect their instability rather than failed assembly ([Figures 5A](#F5){ref-type="fig"}, [5B](#F5){ref-type="fig"}, [S4C](#SD1){ref-type="supplementary-material"}).

In U87 WT cells, COX7A2L protein levels were enhanced up to \~4 fold following 48 hr under nutritional stress induced by carbon source switch from glucose to galactose ([Figures 5C and 5D](#F5){ref-type="fig"}), a paradigm known to stimulate mitochondrial energy metabolism ([@R35]). The existing MRC complexes and SCs in WT and U-KO cells were equally induced after 48 hr in galactose and remained high at 72 hr ([Figure 5E](#F5){ref-type="fig"}), when COX7A2L levels in WT cells had already attenuated ([Figure 5D](#F5){ref-type="fig"}). As expected, coupled and uncoupled oxidation of pyruvate- glutamate-malate + succinate-G3P in permeabilized cells was stimulated in WT cells, but also in U-KO cells, and no differences were observed in substrate contribution ([Figure 5F](#F5){ref-type="fig"}). Therefore, COX7A2L does not have any evident impact in glucose-togalactose nutritional-stress-induced MRC biogenesis and mitochondrial bioenergetics.

Environmental stresses in U87 cells such as acute heat shock (1 hr at 42^○^C; [Figures S3A--S3C](#SD1){ref-type="supplementary-material"}) or exogenous oxidative stress (1 hr in the presence of 100 mM H~2~O~2~; [Figures S3D--S3F](#SD1){ref-type="supplementary-material"}) also induced COX7A2L 2--4 hr after the insult. Yet, these stresses and subsequent recovery did not modify the MRC organization significantly ([Figures S3C and S3F](#SD1){ref-type="supplementary-material"}). The exposition to H~2~O~2~ promoted the equal accumulation of a CORE2-containing sub-SC in U87 WT and U-KO cells ([Figure S3F](#SD1){ref-type="supplementary-material"}), which could be a SC degradation product. As a minor difference, a proportion of U-KO cells higher than that of WT died during the acute oxidative stress, but no differences were detected in the endogenous respiration of the surviving cells ([Figure S3](#SD1){ref-type="supplementary-material"}G). We conclude that the MRC remodeling induced by COX7A2L does not influence mitochondrial bioenergetics during acute cellular stress.

A Mutant COX7A2L Variant Carrying a 6-bp Deletion Present in C57BL/6 Mice Retains the Ability to Bind CIII~2~ but Does Not Rescue SC III~2~+IV Assembly {#S8}
-------------------------------------------------------------------------------------------------------------------------------------------------------

In humans, only one COX7A2L protein of 114 amino acids has been reported (<https://www.uniprot.org/uniprot/O14548>) that is homolog to the long COX7A2L variant present in CD1 mice ([@R33]). To explore the functionality in human cells of the short COX7A2L isoform present in C57BL/6 and BALB/c mouse strains ([@R22]; [@R32]), we generated cell lines constitutively expressing either FLAG-tagged COX7A2L (long) or a mutant version (short) carrying a deletion of amino acids V72 and P73 of human COX7A2L ([Figure 6A](#F6){ref-type="fig"}). Both variants were stably expressed in WT HEK293T and *COX7A2L*-KO cells, which yielded no major differences in the steady-state levels of RC subunits ([Figure 6A](#F6){ref-type="fig"}). MRC organization analysis by 2D-BN/SDS-PAGE revealed that the short COX7A2L variant was imported into mitochondria, where it colocalized with CIII~2~ and SC I+III~2~, but not with any CIV-containing structure ([Figure 6B](#F6){ref-type="fig"}), as previously reported ([@R33]). Whereas expression of the long COX7A2L variant in *COX7A2L*-KO cells restored normal levels of CIII~2~ and SC III~2~+IV, the short variant did not ([Figures 6B--6D](#F6){ref-type="fig"}). Our analyses further disclosed that the expression of either the long or the short COX7A2L variants did not affect the steady-state levels of the respirasomes ([Figures 6C and 6D](#F6){ref-type="fig"}). Similar observations were made in U87 and U-KO cells ([Figure 5B](#F5){ref-type="fig"}). Together, these results support our view ([@R33]) that the 2-amino acid deletion present in the short COX7A2L isoform prevents its association with CIV but does not affect its binding to CIII~2~, an interaction that is not sufficient to promote the formation of the SC III~2~+IV.

Overexpression of CIV-Subunit Tissue-Specific Isoforms in *COX7A2L*-KO Cells Neither Rescues SC III~2~+IV Assembly nor Enhances Respirasome Levels {#S9}
--------------------------------------------------------------------------------------------------------------------------------------------------

Studies in mice suggested that COX7A2L could regulate the formation or stability of the CIV-containing SCs III~2~+IV and I+III~2~+IV~2-n~ in a tissue-specific manner ([@R46]). The relative levels of these SCs were lower in liver than in heart mitochondria from C57BL/6 mice, carrying the short COX7A2L variant, which could be explained by the occurrence of tissue- specific CIV subunit isoforms. Six isoforms have been so far described for the nucleus-encoded COX subunits in mammals: three liver/heart-type pairs of subunits (COX6A1/COX6A2, COX7A2/COX7A1, and COX8--1/COX8--2), the lung-specific iso- form COX4--2, and two testes-specific isoforms, COX6B and COX8--3 ([@R34]). While heart (or muscle) isoforms are expressed in tissues with high aerobic capacity and abundant mitochondria, liver (or non-muscle) isoforms are found in tissues like brain, liver, and kidney that generally contain fewer mitochondria ([@R34]).

An attractive hypothesis suggests that COX7A2L could be replaced by the CIV subunit COX7A2 in the respirasomes, thereby supporting the co-existence of alternative SCs in different tissues ([@R11]; [@R24]; [@R23]). To demonstrate whether the expression of tissue-specific isoforms of CIV subunits differentially affects the assembly of the SCs in the absence of COX7A2L, we attempted to induce the formation of ''tissue-specific'' CIV in WT HEK293T and *COX7A2L*-KO cells, which constitutively express the CIV liver isoforms. To induce the formation of a ''heart-type'' CIV, we overexpressed either FLAG-tagged COX6A2 or COX7A1, and to induce a ''lung-type'' CIV, we overexpressed COX4i2 in both cell types (Figures S5A--S5C). We also analyzed the effect of COX7A2 overexpression in *COX7A2L*-KO cells ([Figures S5A-- S5C](#SD1){ref-type="supplementary-material"}). None of the isoforms rescued the formation of SC III~2~+IV or clearly altered the levels of the respirasomes ([Figure S5D](#SD1){ref-type="supplementary-material"}).

DISCUSSION {#S10}
==========

The biochemical and functional characterization of *COX7A2L*- KO human cell lines presented in this manuscript provide significant insights into the regulation of the MRC structural organization and respiratory metabolism by human COX7A2L. Our data help to clarify conflicting results on COX7A2L function that were primarily obtained in mouse models ([@R13]; [@R20]; [@R22]; [@R32]; [@R33]; [@R46]). In this work, we demonstrate the role of COX7A2L in the coordinated regulation of CIII~2~ and SCs biogenesis. We unambiguously show that COX7A2L is essential to promote the assembly of SC III~2~+IV in human cells, and also the accumulation of large SCs compatible with either respirasomes containing several copies of CIV (I+III~2~+IV~2-n~) or with the recently described MegaC (I~2~+III~2~+IV~2~) ([@R19]). In contrast, COX7A2L is dispensable for the formation of the basic respirasomes (SCs I+III~2~ and I+III~2~+IV~1~), although its absence hampers the assembly efficiency of these MRC structures, thus providing an explanation to the previous controversy. Importantly, COX7A2L establishes a regulatory checkpoint that specifically limits the accumulation of CIII~2~. Physiologically, this adaptation of MRC organization and abundance promoted by COX7A2L is not essential to cope with nutritional, metabolic, or environmental cellular stresses and does not offer an obvious bioenergetics advantage, in contrast with a previous report ([@R22]). These concepts are depicted in a model presented in [Figure 7](#F7){ref-type="fig"} and are discussed below.

COX7A2L was originally presented as a SC assembly factor essential for the incorporation of CIV into SCs III~2~+IV and I+III~2~+IV~1-n~ in mice ([@R22]). In C57BL/6 and BALB/c mouse strains, the lack of residues V72-P73 in a short COX7A2L variant was found to impact COX7A2L stability and its role in the assembly of CIV-containing SCs, including SC III~2~+CIV and the respirasomes ([@R22]). In contrast, the results presented here show that, whereas the SC III~2~+IV is not formed in human *COX7A2L*-KO cells, the respirasomes I+III~2~+IV~1-n~ accumulate to normal levels, consistent with previous data ([@R13]; [@R32]; [@R33]; [@R46]), despite that they are assembled at a slower rate. However, SCs larger than I+III~2~+IV~1~ are unstable, particularly in U87 cells, in which MegaCs may fail to assemble. *In vivo*, the effect of COX7A2L in the SCs assembly rates may vary from tissue to tissue, which could be a contributing factor to explain why large respirasomes containing more than one CIV unit (I+III~2~+IV~2-n~) seem to be less abundant in liver than in heart from C57BL/6 mice ([@R46]).

Regarding the short COX7A2L variant, expression of a human version in *COX7A2L*-KO cells does not support SC III~2~+IV assembly, as seen in C57BL/6 mice ([@R22]),and it does not affect the steady-state levels of SCs I+III~2~+IV~1-n~. Importantly, whereas the short variant retains the ability to bind both CIII~2~ and SC I+III~2~, it does not interact with CIV or CIV-containing respirasomes. In contrast, WT (long) COX7A2L preferentially co-segregates with monomeric CIV, with SCs III~2~+IV and the respirasomes, and, to a minor extent, with CIII~2~ in human HEK293T cells, as it occurs in mouse heart mitochondria and in human 143B osteosarcoma cells ([@R33]). These data are consistent with the views that COX7A2L associates with CIII~2~ and CIV through independent domains to form the SC III~2~+IV ([@R11]; [@R33]; [@R48]), and that COX7A2L binding to CIV requires the correct orientation of a histidine residue at position 73 ([@R11]). Altogether, these results suggest that COX7A2L promotes specific interactions between CIII~2~ and CIV that are essential for their association into SC III~2~+IV, which are probably different to their interactions in the respirasomes, where CI is recruited into the macrostructure ([@R18]; [@R24]; [@R41]; [@R47]). This supports the hypothesis that different pathways may operate to assemble the different SCs ([@R23]). SC III~2~+IV and MegaCs could be assembled by the coming together of the individual complexes, which requires COX7A2L. In contrast, SC I+III~2~+IV~1~ would be assembled in a COX7A2L-independent manner, compatible with the incorporation of newly synthesized sub- units/subassemblies from CIII~2~ and CIV that accumulate once these fully assembled complexes have reached their steady- state levels, into larger structures containing CI intermediates, as we previously proposed ([@R31]).

In our model, the deregulation in the CIII~2~ steady-state levels provoked by the absence of COX7A2L would delay the formation of the basic I+III~2~+IV~1~ respirasome, as well as the further incorporation of additional fully assembled CI or CIV units to generate larger respirasomes or MegaCs. The significant accumulation of CIII~2~ levels was restored to normal by complementation with the long-COX7A2L variant, but not with the short variant, despite its retention of the ability to bind the complex. In this vein, we previously reported that, in cybrid cell lines lacking CIII~2~, the stability of COX7A2L is largely compromised ([@R33]). Furthermore, *de novo* assembly studies in control 143B cells indicated that COX7A2L assembles into a pre-CIII~2~ before the incorporation of the catalytic RISP subunit, whereas COX7A2L only binds CIV once this complex is fully assembled ([@R33]). These negative genetic interactions initially suggested an indirect regulatory role for COX7A2L in regulating CIII~2~ assembly or stability, most probably through the biogenesis of SC III~2~+IV. In this work, we have further demonstrated that the loss of COX7A2L enhances the *de novo* synthesis of CIII~2~ in detriment of the respirasomes, and therefore COX7A2L establishes a threshold to the accumulation of CIII~2~ in the steady state required to ignite respirasome assembly ([@R31]).

Finally, the impact of the MRC structural remodeling promoted by COX7A2L on mitochondrial physiology has also been a source of controversy. It was proposed that COX7A2L-dependent SC organization remodeling provides a mechanism for the physiological regulation of energy metabolism in mammals by providing alternate paths for electrons derived from the catabolism of specific substrates ([@R22]). In this model, electron flux from CI to CIII~2~ (carried by NADH) would proceed essentially within the CI-containing SCs, whereas electron flow from CII (carried by FAD) would preferentially occur through free CIII~2~ and SC III~2~+IV ([@R22]). ATP production and respiration rates were found higher in mouse liver mitochondria and permeabilized fibroblasts with the unstable short-COX7A2L variant, both in the presence of pyruvate + malate (NADH-linked substrates) or succinate (FAD-linked substrate), whereas maximal respiration and ATP production in cells expressing long-COX7A2L required substrates for both electron transfer paths ([@R22]). However, other groups reported lower mitochondrial respiration and ATP synthesis in muscle ([@R20]) and liver ([@R38]) from *COX7A2L*-KO mice or no effect of short-COX7A2L on mouse heart mitochondrial respiration ([@R32]). Our human *COX7A2L*-KO cellular models displayed no differences with WT cells in coupled endogenous cell respiration, or in single and combined substrate (pyruvate- glutamate-malate or succinate-G3P) oxidation, indicating a minor functional role of COX7A2L in normal cultured cell physiological conditions. Similar results were obtained when the cultures were exposed to several nutritional, oxidative, and environmental cellular stresses, even though they actually induce COX7A2L protein by 4- to 10-fold. Altogether, our results contest the highly controversial role of COX7A2L in MRC SCs organization that has been hypothesized to maximize mitochondrial bioenergetics efficiency ([@R6]; [@R22]).

A potential caveat of our studies is the use of cell culture models, which are maintained in conditions that could differ *in vivo*, particularly regarding tissue oxygen and nutrient availabilities. However, similar results were obtained in two different cell models and an array of culture conditions. Our data serve to clarify some of the current discrepancies regarding the impact of COX7A2L on the organization and function of the MRC complexes. We conclude that the role of COX7A2L in SC III~2~+IV assembly, which is well established in the literature, and in the assembly/stability of higher SCs or MegaCs, has no impact in mitochondrial bioenergetics in any of the conditions tested. One could claim that the excess of free CIII~2~ that accumulates when SC III~2~+IV is absent could compensate for the instability of MegaCs and the slower SC assembly kinetics observed in *COX7A2L*-KO cells, but if this occurs, it is not via preferential substrate utilization, as also supported by other groups ([@R7]; [@R15]; [@R44]). Alternatively, COX7A2L could be part of a response to accelerate CIII- containing SCs assembly when needed to preserve stability of individual complexes ([@R2]) or to minimize ROS production ([@R27]), possibilities that warrant future research efforts.

STAR★METHODS {#S12}
============

KEY RESOURCES TABLE {#S13}
-------------------

  REAGENT or RESOURCE                                     SOURCE                     IDENTIFIER
  ------------------------------------------------------- -------------------------- ------------------------------------
  Antibodies                                                                         
  ATP5A                                                   Abcam                      Cat\# ab14748 RRID: AB_301447
  β-ACTIN                                                 Abcam                      Cat\# ab8227 RRID: AB_2305186
  BCS1-L                                                  Abcam                      Cat\# ab102808 RRID: AB_10859410
  CORE1                                                   Abcam                      Cat\# ab110252 RRID: AB_10863633
  CORE2                                                   Abcam                      Cat\# ab14745 RRID: AB_2213640
  COX1                                                    Abcam                      Cat\# ab14705 RRID: AB_2084810
  COX2                                                    Abcam                      Cat\# ab110258 RRID: AB_10887758
  COX4I1                                                  Abcam                      Cat\# ab14744 RRID: AB_301443
  COX4I2                                                  Abcam                      Cat\# ab70112 RRID: AB_2085283
  COX5A                                                   Sigma                      Cat\# HPA027525
  COX5B                                                   Santa Cruz                 Cat\# sc-374417 RRID: AB_10988066
  COX6A1                                                  Sigma                      Cat\# HPA062394 RRID: AB_2684749
  COX6A2                                                  Abcam                      Cat\# ab103139 RRID: AB_10710958
  COX7A1                                                  Abcam                      Cat\# ab134989
  COX7A2L                                                 ProteinTech                Cat\#11416--1-AP RRID: AB_2245402
  FLAG-tag                                                Sigma                      Cat\# F3165 RRID: AB_259529
  HSP70 (HSPA6)                                           Origene                    Cat\# TA501950 RRID: AB_11124627
  NDUFA9                                                  Abcam                      Cat\# ab14713 RRID: AB_301431
  NDUFS1                                                  Abcam                      Cat\# ab52690 RRID: AB_2151096
  RISP                                                    Abcam                      Cat\# ab14746 RRID: AB_301445
  SDHA                                                    Abcam                      Cat\# ab14715 RRID: AB_301433
  SOD2                                                    Sigma                      Cat\# HPA001814 RRID: AB_1080134
  TIM50                                                   Abcam                      Cat\# ab109527 RRID: AB_10858241
  TOM20                                                   Santa Cruz                 Cat\# sc-11415 RRID: AB_2207533
  b-TUBULIN                                               Sigma                      Cat\# C4585 RRID: AB_258868
  UQCRB                                                   Abcam                      Cat\# ab190360
  VDAC1                                                   Abcam                      Cat\# ab14734 RRID: AB_443084
  2^○^ Ab-mouse                                           Rockland Immunochemicals   Cat\# 610--103-121 RRID: AB_218457
  2^○^ Ab-rabbit                                          Rockland Immunochemicals   Cat\# 611--1302 RRID: AB_219720
                                                                                     
  Chemicals, Peptides, and Recombinant Proteins                                      
                                                                                     
  Dulbecco's Modified Eagle Medium (DMEM)                 Invitrogen                 Cat\# 31966--047
  Fetal bovine serum (FBS)                                Sigma                      Cat\# 12303C
  Lipofectamine 2000                                      Invitrogen                 Cat\# 1168019
  Opti-MEM I Reduced Serum Medium                         ThermoFisher \#            Cat\# 31985062
  n-dodecyl-b-d-maltoside (DDM)                           Sigma                      Cat\# 5172
  Digitonin, High Purity                                  Calbiochem                 Cat\# 300410
  Native PAGE 20X Running Buffer                          Novex-Life Technologies    Cat\# BN2001
  Native PAGE 20X Cathode Buffer Additive                 Novex-Life Technologies    Cat\# BN2002
                                                                                     
  Critical Commercial Assays                                                         
                                                                                     
  TNT T7 Quick Coupled Transcription/Translation System   Promega                    Cat\# L1170
  SuperSignal West Femto Maximum Sensitivity Substrate    ThermoFisher               Cat\# 34095
                                                                                     
  Experimental Models: Cell Lines                                                    
                                                                                     
  HEK293T                                                 ATCC                       Cat\# CRL-3216
  Glioblastoma U87                                        ATCC                       Cat\# HTB-14
                                                                                     
  Oligonucleotides                                                                   
                                                                                     
  *COX7A2L*-short-Forward: GTTTTTCCAGAAAGCTGATGGT         Sigma                      This paper
  *COX7A2L*-short-Reverse: GCCTCGTTTCAGGTAGAC             Sigma                      This paper
  *COX7A2L*-KO-Forward: AAGTTAGGCGATCTTCGGGC              Sigma                      This paper
  *COX7A2L*-KO-Reverse: GCTCGGACATGAGAAGTGGC              Sigma                      This paper
  SAS1_Hs01:                                              Sigma                      Cat\# oligo 3019431149--000060
  SAS1_Hs02:                                              Sigma                      Cat\# oligo 3019431149--000070
                                                                                     
  Recombinant DNA                                                                    
                                                                                     
  TAL Effector (F)- *COX7A2L:* TGGGCGTCATGTACTACAA        Invitrogen                 N/A
  TAL Effector (R)- *COX7A2L:* GCAGAAGTTGGCAGGAGCA        Invitrogen                 N/A
  *UQCR11* in pReceiver-B31                               GeneCopoeia                Cat\# EX-I0287-B31
  *UQCRB* in pReceiver-B31                                GeneCopoeia                Cat\# EX-F0223-B31
  *UQCRFS1 or RISP in* pReceiver-B31                      GeneCopoeia                Cat\# EX-A3744-B31
  *COX7A2L*- Myc-DDK in pCMV6-Entry                       Origene                    Cat\# RC202697
  *COX7A1*- Myc-DDK in pCMV6-Entry                        Origene                    Cat\# RC201154
  *COX4I1*- Myc-DDK in pCMV6-Entry                        Origene                    Cat\# RC209374
  *COX4I2*- Myc-DDK in pCMV6-Entry                        Origene                    Cat\# RC209204
  *COX6A1*- Myc-DDK in pCMV6-Entry                        Origene                    Cat\# RC210485
  *COX6A2*- Myc-DDK in pCMV6-Entry                        Origene                    Cat\# RC206539
  pCMV6-A-Entry-Hygro                                     Origene                    Cat\# PS100024
  *COX7A2L*-Myc-DDK in pCMV6-A-Entry-Hygro                This paper                 N/A
                                                                                     
  Software and Algorithms                                                            
                                                                                     
  SPSS                                                    IBM, v 21.0                N/A
  ImageJ                                                  NIH                        <https://imagej.nih.gov/ij/>
  GraphPad Prism                                          GraphPad Software v.5.0a   N/A
  ImageLab                                                BioRad, v 6.0.1            N/A
                                                                                     
  Other                                                                              
                                                                                     
  Pre-cast NuPAGE 4%--12% Bis-Tris gels                   Invitrogen                 Cat\# NP0321BOX
  Pre-cast NativePAGE 3%--12% Bis-Tris gels               Invitrogen                 Cat\# BN2011BX10

CONTACT FOR REAGENT AND RESOURCE SHARING {#S14}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Antoni Barrientos, Ph.D. (<abarrientos@med.miami.edu>).

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S15}
--------------------------------------

### Human cell lines, transfection and cell culture {#S16}

HEK293T (CRL-3216) and glioblastoma U-87 (HTB-14) cells were obtained from ATCC and cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM, Life Technologies) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1 mM sodium pyruvate, 50 mg/ml uridine and antibiotics at 37^○^C under 5% CO~2~. Analysis for mycoplasma contamination was routinely performed.

### Nutritional and environmental stress conditions {#S17}

For some experiments cells were exposed to nutritional, OXPHOS bioenergetics an environmental stressors. Nutritional stress was induced by transferring cells from glucose-containing to galactose-containing media and samples were analyzed over increasing times (12 to 48 hours). OXPHOS bioenergetics stress was induced with MRC complex I inhibitors: cells were exposed to 10 nM rote- none, 1.2 mM piericidin A or the control vehicle (0,05% or 8,5 mM ethanol) for 24 hours. Heat stress was induced by exposing cultures to 42^○^C for 1 hour and oxidative stress by supplementing the media with 100 mM H~2~O~2~ for 1 hour. Following heat or oxidative stress, the media was changed and the cultures incubated in non-stress conditions before samples were collected after increasing times of recovery (0 to 8 hours).

METHOD DETAILS {#S18}
--------------

### Key reagents {#S19}

Tables presenting the list of antibodies, recombinant DNAs, oligonucleotides and siRNA oligoribonucleotides used in this study are included in the supplementary material.

### Plasmid transfection {#S20}

To create stable human *COX7A2L* knockout (KO) lines in HEK293T and U87 cells, we used a pair of TALEN constructs obtained from Thermo-Invitrogen. The left and right TALEN of the pair were designed to target the TGGGCGTCATGTACTACAA and the GCAGAAGTTGGCAGGAGCA DNA sequences, respectively, at the *COX7A2L* locus ([see key reagents tables](#S13){ref-type="sec"}). HEK293T or U87 cells grown on a 6-well plate at 30% confluency were transfected with 4 mg of the right and left TALEN plasmids as a pair using 5 mL of Lipofectamine 2000 (Thermo Fisher) pre-incubated in 300 mL of Opti-MEM (ThermoFisher). After 4 hours of incubation, the media were changed to complete DMEM medium. After 3--6 times of repetitive transfections every three days, cells were collected, diluted in complete DMEM medium and seeded as single cells in multiple 96 well plates. In some repetitions, single cells were isolated using Fluorescence Activated Cell Sorting (FACS). The surviving colonies screened by immunoblotting against COX7A2L and by genotyping, as reported ([@R8]). For genotyping, *COX7A2L* was sequenced using oligonucleotides *COX7A2L*-KO-Forward and *COX7A2L*-KO-Reverse ([see Key resources table](#S13){ref-type="sec"})

The *COX7A2L*-KO cell lines were reconstituted with Myc-DDK-tagged variants (long or short) of COX7A2L. *COX7A2L*-Myc-DDK was cloned under the control of a CMV promoter in the pCMV6-A-Entry-Hygro plasmid (Origene, PS100024) using *Sfa*AI and *Mss*I sites. The short version of mouse COX7A2L comprises an in-frame 6 base pair deletion that led to the absence of 2 amino acids (V72 and P73) ([@R22]). To generate the short variant of human COX7A2L, we used the Q5® Site-Directed Mutagenesis Kit from NEB. \~20 ng of template DNA extracted from HEK293T cells were used, along with the primers COX7A2L-short-F: 5^0^-GTTTTTCCAGAAAGCTGATGGT-3^0^ (forward) and COX7A2L-short-R: 5^0^-GCCTCGTTTCAGGTAGAC-3^0^ (reverse), designed to flank the region to be deleted. After exponential amplification and the treatment with kinase and ligase, 5 ml of the reaction were transformed NEB 5-alpha competent *E.coli* cells using the pCMV6-A-Entry-Hygro plasmid (Origene).

For transfection of COX7A2L-Myc-DDK-Hygro constructs, we used 10 mL of Lipofectamine™ (Thermo Fisher) mixed with 4 mg of vector DNA in OPTIMEM-I media (GIBCO) according to the manufacturer's instructions. Two days after transfection, the media was supplemented with 200 mg/ml of hygromycin and drug selection was maintained for at least 21 days.

### Whole Cell extracts and Mitochondrial isolation {#S21}

Whole cell extracts were obtained by solubilization in RIPA buffer (25 mM Tris-HCl pH 7.6; 150 mM NaCl; 1% NP-40; 1% sodium deoxycholate and 0.1% SDS) with 1 mM PMSF and 1x mammalian protease inhibitor cocktail (Sigma). Extracts were cleared by 5 minutes centrifugation at 10,000 g at 4^○^C.

Mitochondria-enriched fractions were isolated from at least ten 80% confluent 175 cm^2^ flasks as described previously ([@R8]; [@R17]; [@R31]). To extract mitochondrial proteins in native conditions, mito- chondria were pelleted and solubilized in 200 mL buffer containing 1.5 M aminocaproic acid and 50 mM Bis-Tris (pH 7.0). After optimizing solubilization conditions, we decided to use digitonin at a concentration of 4 g/g protein. In some experiments, lauryl maltoside (LM) was used at 1%. Solubilized samples were incubated on ice for 15 min and centrifuged for 30 min at 10,000 xg at 4^○^C, and the supernatant was combined with 20 mL of sample buffer (750 mM aminocaproic acid, 50 mM Bis-Tris, 0.5 mM EDTA, 5% Serva Blue G-250) prior to loading.

### Blue Native Electrophoresis and In-Gel Activity Assays {#S22}

Native PAGE Novex® 3%--12% Bis-Tris Protein Gels (Life Technologies) gels were loaded with 60--80 mg of mitochondrial protein or 400 mg of total cell extracts prepared in the presence of either lauryl maltoside (LM) or digitonin at the protein-detergent ratios indicated in the figure legends. After electrophoresis, proteins were transferred to PDVF or nitrocellulose membranes and used for immunoblotting. Duplicate gels were further used for *in-gel* activity (IGA) assays and for second-dimension (2D) 10% SDS-PAGE gels.

### SDS-PAGE and immunoblotting {#S23}

Protein concentration was measured with the BCA reagent (Thermo Scientific). 20--60 mg of mitochondrial protein extract was separated by SDS--PAGE in the Laemmli buffer system ([@R21]). Then, proteins were transferred to nitrocellulose membranes at 40 V overnight and probed with specific primary antibodies listed in the Key reagents Table. Peroxidase-conjugated anti-mouse and anti-rabbit IgGs were used as secondary antibodies (Molecular Probes). Immunoreactive bands were detected with an ECL prime Western Blotting Detection Reagent (Amersham) in a ChemiDoc MP Imager (Biorad) or by exposition to X-ray films. Optical densities of the immunoreactive bands were measured using the ImageLab (Biorad) software or the ImageJ software in digitalized images.

### Characterization of the mitochondrial respiratory chain and oxidative phosphorylation system {#S24}

Mitochondrial respiratory chain enzyme activities were performed according to established methods ([@R28]), and expressed relative to the citrate synthase activity.

Endogenous cell respiration was measured polarographically at 37^○^C using a Clark-type electrode from Hansatech Instruments (Norfolk, United Kingdom). Substrate-driven respiration was assayed in digitonin-permeabilized cultured cells as reported ([@R5]). Briefly, trypsinized cells were washed with permeabilized-cell respiration buffer (PRB) containing 0.3 M mannitol, 10 mM KCl, 5 mM MgCl~2~, 0.5 mM EDTA, 0.5 mM EGTA, 1 mg/ml BSA and 10 mM KH~3~PO~4~ (pH 7.4). The cells were resuspended at \~4 3 10^6^ cells/ml in 1.5 mL of the same buffer air-equilibrated at 37 ^○^C supplemented 10 units of hexokinase and 2 mM ADP. One ml of cell suspension was immediately placed into the polarographic chamber to measure endogenous respiration.

High-resolution oxygen consumption rate of digitonin-permeabilized cells was performed as described previously ([@R39]) at 37^○^C, using 1 million cells diluted in 2 mL of respiratory buffer (120 mM sucrose, 50 mM KCl, 20 mM Tris-Base, 4 mM KH2PO4, 2 mM MgCl~2~, 1 mM EDTA, pH 7.2) using an Oxygraph-2K (Oroboros). Briefly, cells were permeabilized with 0.02 mg/ml digitonin. The oxygen consumption rate under phosphorylating condition was assessed using either NADH-linked substrates (10 mM glutamate, 10 mM pyruvate and 5 mM malate), or FADH-linked substrates (10 mM succinate plus 5 mM glycerol-3-phosphate) in the presence of 2.5 mM ADP. The non-phosphorylating state was obtained after ATP synthesis inhibition using 0.75 mg/ml oligomycin. Mitochondrial respiration was uncoupled by successive addition of up to 0.4 mM CCCP to reach maximal oxygen consumption. To assess the contribution of NADH-linked and FADH-linked substrates to total oxygen consumption, respiration was assessed in the presence of both kinds of substrates. Subsequently, complex I and complex II activities were sequentially inhibited using respectively 1.2 mM piericidin A and 3 mM malonate. Afterward, 5mM of antimycin A was added to validate the mitochondrial origin of the oxygen consumption measured.

### De novo mitochondrial respiratory chain complex and supercomplex assembly {#S25}

To follow the assembly kinetics of MRC complexes and supercomplexes, we depleted cells of the structures containing mtDNA- encoded subunits by treating the cultures with doxycycline, a reversible inhibitor of mitochondrial translation as reported ([@R31]). We cultured WT (HEK293 or U87) control and *COX7A2L*-KO cells for 6 days in the presence of 15 mg/ml doxycycline. To follow the accumulation of newly synthesized MRC complexes and their further association into super complexes, samples were collected at different time points (0, 6, 15, 24, 48, 72, and 96 hours) after doxycycline removal. Digitonin- solubilized mitochondrial particles were separated by BN-PAGE and analyzed by immunoblotting.

### Overexpression of Complex IV tissue-specific (liver and heart) subunit isoforms in COX7A2L-KO cells {#S26}

Genes coding for selected liver and heart Complex IV subunit isoforms (*COX4I1. COX4I2, COX6A1, COX6A2, COX7A1* and *COX7A2*) were cloned in frame with a Myc-DDK-tag into pCMV6 plasmid carrying a hygromycin resistance cassette. Each construct was transfected into the *COX7A2L*-KO cell line, by using 10 mL of Lipofectamine™ (Thermo Fisher) mixed with 4 mg of vector DNA in OPTIMEM-I media (GIBCO), according to the manufacturer's instructions. Two days after transfection, the media was supplemented with 200 mg/ml hygromycin and drug selection was maintained for at least 21 days.

### In organello import of radiolabelled recombinant proteins {#S27}

Plasmids with CIII subunit ORFs for *in organello* import were obtained from GeneCopoeia™. pReceiver-B31 vectors have *UQCR11* (EX-I0287-B31) and *UQCRFS1 or RISP* (EX-A3744-B31) ORFs under the control of the T7 promoter. Radiolabeled UQCR11 and UQCRFS1 proteins were synthesized in the presence of \[^35^S\]-methionine, using the TNT T7 Quick Coupled Transcription/Translation System (Promega). Import experiments were performed by incubating radiolabeled precursor subunits with 200 mg of freshly isolated mitochondria prepared as reported ([@R17]) in presence 33 mL of import buffer (20 mM HEPES-KOH pH 7.4, 600mM mannitol, 16 mM MgCl~2~, 5 mM ATP, 225 mM KCl, 0.1 mg/ml pyruvate kinase, 5 mM methionine and 3% (w/v) fatty acid-free bovine serum albumin) in a total volume of 200 ml in STE buffer (0.32 M sucrose, 1 mM EDTA, 10 mM Tris-HCl pH 7.4), at 37^○^C for increasing times (5 to 60 min). To assess import dependence of mitochondrial membrane potential, control samples were incubated with 10 mM of CCCP. For SDS-PAGE analysis, samples were split into two aliquots and treated with or without 100 mg/ml proteinase K (Sigma) for 20 min on ice, before stopping the reaction with 1 mM PMSF for 10 min. Mitochondria were pelleted at 8,000 xg for 8 min at 4^○^C and resuspended in 100 ml of STE buffer for their further analysis. For BN-PAGE analysis, mitochondria samples were subjected to protease treatment and pelleted before undergoing the analysis as described above.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S28}
---------------------------------------

Unless indicated, all experiments were performed at least in triplicate and results were presented as mean ± standard deviation (SD) of absolute values or percentages of control. Statistical *p* values were obtained by application of the Mann-Whitney *U* test using the SPSS v21.0 program. p \< 0.05 was considered significant test (\*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001). Information on biological and technical replicates and statistical significance is included in the figure legends.
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![TALEN-Mediated Generation of COX7A2L-KO Clones in HEK293T Cells\
(A) Schematic representation of the first exon of the *COX7A2L* locus and the sequences of recognition sites of the two TALEN pairs.\
(B) Immunoblot analysis of the steady-state levels of COX7A2L in HEK293T (WT) and TALEN-transfected HEK293T cell lines. VDAC was used as a loading control.\
(C) *COX7A2L* alleles in TAL-*COX7A2L* clones. The DNA numbering refers to the coding sequence (c.) and the protein (p.) number to the predicted full polypeptide ([@R14]). C, compound; Mut, mutant; Hetero, heterozygous; Homo, homozygous; del, deletion; -, position before starting ATG.\
(D) BN-PAGE analysis of whole cells extracted with digitonin (detergent/protein ratio, 4:1) separated in a 4%--8% linear gradient polyacrylamide gel, followed by CI in-gel activity (IGA) or immunoblotting with the indicated antibodies. The identity of MRC complexes and SCs is indicated in the margins. MegaC, megacomplexes probably containing more than one copy of CI, CIII~2~, and CIV. See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1514168-f0002){#F1}

![COX7A2L-KO Cells Display Absence of SC III2+IV with Normal Respirasome Levels and Altered Accumulation of CIII2\
The effect of COX7A2L absence on MRC complex assembly was investigated in two *COX7A2L*-KO clones, clone 1 (KO1) and clone 2 (KO2), compared with the control HEK293T cells (WT).\
(A) Mitochondria extracted with a digitonin/protein ratio of 4:1 (g/g) and analyzed by BN-PAGE, followed by CI- and CIV-IGA assays, or alternatively, by immunoblotting using the indicated antibodies.\
(B) Subsequent 2D-BN/SDS-PAGE and immunoblot analyses were performed with antibodies against COX7A2L and the indicated OXPHOS subunits.\
(C) To address the relative amount of CIII~2~ in *COX7A2L*-KO cells, the signals from the CORE2 antibody from four BN-PAGE experiments were quantified by densitometry, normalized by CII, and indicated as mean ± SD.\
(D) BN-PAGE analyses in whole-cell extracts prepared in the presence of digitonin (detergent/protein ratio, 4:1) or 1% lauryl maltoside (LM). The CIII~2~ signals were quantified and normalized by CII using the histogram function of the Adobe Photoshop program on digitalized images, and the values were expressed relative to the control. Error bars represent the mean ± SD of four independent experiments.\
(E) Spectrophotometric measurements of the individual activities of MRC complexes I to IV (CI--CIV) in WT and *COX7A2L*-KO cells. Enzyme activities are expressed as cU/U citrate synthase (CS). Error bars represent the mean ± SD of four repetitions. \*p \< 0.05; \*\*p \< 0.01. MegaC, megacomplexes probably containing more than one copy of CI, CIII~2~, and CIV. I+III~2~+IV~n~, SCs containing CI, CIII~2~, and CIV. I+III~2~, SC containing CI and CIII~2~. III~2~+IV, SC containing CIII~2~ and CIV. III~2~, complex III dimer (CIII~2~). IV, complex IV; IV~2~, complex IV dimer (CIV~2~). II, complex II. Subcomplexes that contain COX1 and COX4 are indicated. Apparent subcomplexes that contain CORE2 are antibody artifacts that disappear in 2D-BN/SDS-PAGE gels. See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1514168-f0003){#F2}

![COX7A2L-KO Cells Have Enhanced Rate of De Novo CIII2 Biogenesis and Delayed Respirasomes Formation\
(A--E) HEK293T (WT) and *COX7A2L*-KO clone 1 (KO1) cells were cultured for 8 days in the presence of 15 mg/mL doxycycline and collected at different time points (0, 6, 15, 24, 48, 72, and 96 hr) after doxycycline removal. Mitochondria prepared from these samples were extracted with a digitonin/protein ratio of 4 g/g and analyzed by BN-PAGE in combination with (A) CI-IGA assays or (C) immunoblotting with the indicated antibodies. (B) Mean CI activity recovery after doxycycline removal quantified from (A).\
(C) Mean incorporation rates of CORE2 subunit in CIII~2~, and of COX1 (not shown) and COX5A subunits in CIV and CIV~2~, or their assembly kinetics in the I+III~2~+IV~1-n~ respirasomes.\
(D) The signals from three independent experiments (as in C) for WT and KO cells were quantified and normalized by CII. Time point values are expressed as percentages of the untreated cells (SS) and indicated as means ± SD. \*p \< 0.05, \*\*p \< 0.01. I+III~2~+IV~n~, SCs containing CI, CIII~2~, and CIV. III~2~+IV, SC containing CIII~2~ and CIV; III~2~, complex III dimer (CIII~2~); IV, complex IV; IV~2~, complex IV dimer (CIV~2~); II, complex II.\
(E) For two doxycycline experiments, samples were analyzed by SDS-PAGE for the steady-state levels of CIII subunits CORE2 and RISP. On the right panel, the signals were quantified and plotted as ratio of SDHA. The values for the two independent experiments did not differ by more than 5%.\
(F) Steady-state levels of the indicated CIII subunits in HEK293T WT, KO1, and KO2 cell lines. On the right panel, the signals of CORE2 and RISP were quantified and expressed as ratio of the signal of ACTIN, used as a loading control. Error bars represent the mean ± SD of three independent experiments.\
(G) Simplified current model of CIII assembly depicting the order of subunit incorporation and time of dimerization, modified from [@R16].\
*(H) In organello* import of the indicated recombinant proteins synthesized in a reticulocyte system in the presence of ^35^S-methionine. The import assays were performed for 30 min in the absence or presence of the uncoupler CCCP to disrupt the mitochondrial membrane potential (J). Following import, an aliquot was treated with proteinase K to digest non-imported precursor proteins. M, mature; p, precursor.\
(I and J) BN-PAGE analysis of the incorporation of the indicated radiolabeled recombinant proteins into CIII assembly intermediates, dimer, and SCs in HEK293T WT and KO1 cells during increasing times from 5 to 60 min. Import assays were performed in duplicates with similar results. Sub, subassemblies. The asterisk indicates small subassemblies that may correspond to the protein being imported bound to specific chaperones.](nihms-1514168-f0004){#F3}

![COX7A2L-KO Cells Are Capable of Normal OXPHOS Performance\
Respiration of permeabilized *COX7A2L* KO and control HEK cells cultivated on DMEM high glucose (A--D) or DMEM high glucose supplemented with 1.2 mM piericidin A, a CI inhibitor (G).\
(A) Respiration of digitonin-permeabilized HEK293T cells assessed in the presence of Pyr-Glu-Mal: pyruvate (10 mM), glutamate (10 mM), and malate (5 mM) under different respiratory states (phosphorylating, resting, and uncoupled) and piericidin A-sensitive respiration (PinA sens).\
(B) Respiration of digitonin-permeabilized HEK293T cells assessed in the presence of Suc-G3P: succinate (10 mM) and glycerol-3-phosphate (5 mM) under different respiratory states (phosphorylating, resting, and uncoupled) and malonate-sensitive respiration (Malo sens).\
(C) Respiration of digitonin-permeabilized HEK cells incubated with Pyr-Glu-Mal and Suc-G3P. The Piericidin A- (PinA sens) and Malonate-sensitive (Malo sens) respiration are determined under uncoupled conditions.\
(D) Respective contribution of NADH and succinate dehydrogenases in providing electrons to sustain uncoupled respiration assessed with all substrates under uncoupled state.\
(E) OXPHOS stress paradigm based on *in cello* CI inhibition with rotenone or piericidin A.\
(F) Effect of 24-hr incubation in the presence of 50 nM rotenone in HEK293T WT and KO1 cells on SC stability, analyzed in digitonized cell extracts by BN-PAGE and immunoblotting with the indicated antibodies.\
(G) Respiration analysis of HEK cells cultivated during 48 hr in presence of CI inhibitor (piericidin A). The respiration of digitonin-permeabilized cells incubated with Pyr-Glu-Mal and Suc-G3P assessed under different respiratory states (phosphorylating, resting, and uncoupled). The piericidin A (PinA sens)-, malonate (Malo sens)-, and remaining antimycin A (AA)-sensitive respirations are determined under uncoupled conditions. The graph on the right side represents the respective contribution of CI and CII in providing electrons to sustain uncoupled respiration. In all the panels, error bars represent the mean ± SD of four biological repetitions. See also [Figure S3](#SD1){ref-type="supplementary-material"}.](nihms-1514168-f0005){#F4}

![A Nutritional Challenge Induced by Switching the Carbon Source in the Media from Glucose to Galactose Does Equally Enhance Mitochondrial Bioenergetics Parameters in WT and COX7A2L-KO Cells\
(A and B) Characterization of glioblastoma U87 WT and *COX7A2L*-KO (U-KO1) cells. The KO cells were stably transfected with an empty vector (ev) or constructs to express the long or short versions of COX7A2L. (A) and (B) show the BN-PAGE analysis of whole cells extracted with digitonin (detergent/protein ratio, 4:1) separated in a 4%--8% (A) or a 3%--12% (B) linear gradient polyacrylamide gel, followed by CI in-gel activity (IGA) (A) or immunoblotting with the indicated antibodies (B). The identity of MRC complexes and SCs is indicated in the margins. MegaC, megacomplexes probably containing more than one copy of CI, CIII~2~, and CIV.\
(C) Scheme depicting the carbon source switch paradigm used in this study.\
(D) Time course quantification of COX7A2L induction by galactose in U87 WT cells. The graphs represent a quantification of the signals in three independent experiments, with error bars representing the mean ± SD.\
(E) Mitochondria extracted with a digitonin/protein ratio of 4:1 (g/g) from cells grown in either glucose-containing (Gluc) or galactose-containing (Gal) medium and analyzed by BN-PAGE, followed by CI-IGA assays or, alternatively, by immunoblotting using the indicated antibodies. The red arrows indicate MegaCs exclusively detected in WT cells.\
(F) Respiration of glioblastoma U87 cells assessed under different respiratory states (phosphorylating, resting, and uncoupled) and respective contribution of NADH and succinate dehydrogenases to the uncoupled respiration cultured in DMEM-glucose (upper panel), or DMEM-galactose (lower panel). Error bars represent the mean ± SD of four biological repetitions. See also [Figure S4](#SD1){ref-type="supplementary-material"}.](nihms-1514168-f0006){#F5}

![The Short-COX7A2L Variant Binds to CIII2 but Does Not Rescue SC III2+IV Assembly in COX7A2L-KO Cells\
Control HEK293T cells (WT) and both *COX7A2L*- KO (KO1 and KO2) clones carrying an empty vector (ev) or constructs to overexpress COX7A2L-Myc- DDK (long) or short-COX7A2L-Myc-DDK (short) were used in the following experiments.\
(A) SDS-PAGE followed by immunoblotting to estimate steady-state levels of endogenous COX7A2L (\~12.6 kDa) from exogenous COX7A2L-Myc-DDK (\~16.2 kDa). Membranes were also incubated with antibodies that recognize the indicated OXPHOS subunits.\
(B). 2D-BN/SDS-PAGE and immunoblotting using digitonin-solubilized mitochondrial extracts (detergent/protein ratio, 4:1) and the indicated antibodies. (C and D) BN-PAGE followed by immunoblotting in digitonized whole-cell extracts (C) or by CI-IGA and CIV-IGA assays and/or immunoblotting in digitonized isolated mitochondria (D). Membranes were incubated with the indicated antibodies. I+III~2~+IV~n~, SCs containing CI, CIII~2~, and CIV. I+III~2~, SC containing CI and CIII~2~. III~2~+IV, SC containing CIII~2~ and CIV. III~2~, complex III dimer (CIII~2~). IV, complex IV; IV~2~, complex IV dimer (CIV~2~); II, complex II. Subcomplexes that contain COX1 are indicated as subCOX1. In (D), an unidentified band running a bit faster than the SC III~2~+IV cross-reacting with the COX5B antibody (Ab) (but not with the CORE2 Ab) is indicated with an asterisk.](nihms-1514168-f0007){#F6}

![Structural and Functional Rearrangements of the RC in the Absence of COX7A2L\
(A) Fully assembled CIII~2~ and CIV accumulate until they reach a threshold that ignites SC III~2~+IV and respirasome assembly at rates arbitrarily indicated by arrows. In the absence of COX7A2L, CIII~2~ levels are \~2--3-fold, SC III~2~+IV is not formed, and the assembly kinetics of CIII-containing SCs is slower.\
(B) In physiological, nutritional, and environmental stress conditions, individual and simultaneous oxidation of NADH- and FAD-linked substrates is similar in WT and *COX7A2L*-KO cells. Mitochondrial CI, CIII~2~, and CIV are represented in blue, green, and red, respectively. COX7A2L is represented as a black stick.](nihms-1514168-f0008){#F7}

###### Highlights

-   *COX7A2L*-knockout human cells lack SC III~2~+IV and some megacomplexes

-   *COX7A2L*-KO cells have enhanced CIII~2~ steady-state levels and assembly rate

-   *COX7A2L*-KO cells have slower respirasome assembly but normal steady-state levels

-   COX7A2L-dependent MRC remodeling does not affect mitochondrial bioenergetics
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